PATENT CLAIM ANALYSIS

Application Number: 15763807
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["544", "238000"]

Abstract:
The present invention relates to a benzamide derivative of general formula I, a drug composition containing same and a use thereof as a drug, wherein the definitions of R 1 , Z and Q are as described in the description.

Claim (Index 22):
A method for preventing and/or the treating symptoms or diseases mediated by p38 kinase activity or mediated by the cytokines produced by p38 kinase activity comprising administering to a subject a therapeutically effective amount of the compound, or the tautomer, the optical isomer and the pharmaceutically acceptable salt thereof according to  claim 14 .

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.30303
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10522955', '10581305', '12713448', '12875218', '12936784']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.804943996723829
- 35 USC 102 Novelty (BERT): 0.5292846405132451
- Combined Prediction Score: 0.7773780611027705
- Mean Citation Score: 363.297944
- Max Citation Score: 374.7806
- Similarity Product: 259.51119222990275

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test